TSXV:CLAS.H - Post by User
Post by
Red~Oneon Mar 30, 2022 9:48am
66 Views
Post# 34558541
RE:N.O. in the news, No Clas
RE:N.O. in the news, No ClasNext time do your own DD.
"...best-in-class technology that improves the clinical care of patients requiring inhaled nitric oxide therapy. GENOSYL has gained significant market traction with adoption by some of the top hospitals in the US."
Dec 21, 2021, 09:40 ET
https://www.prnewswire.com/news-releases/vero-biotech-receives-funding-from-mvm-partners-to-accelerate-growth-301449098.html